CD1D and neoplasm: LAVA-051 is a bispecific single domain antibody that directly engages CD1d and the Vδ2-T cell receptor chain of Vγ9Vδ2-T cells and additionally stabilizes the interaction between CD1d and type 1 natural killer T cells to mediate potent killing of CD1d-expressing tumor cells [74].